HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 2 (2nd HARP Pilot Intervention)
Key facts
- Where
- West Haven, United StatesSee the site
- Phase
- Phase 1
Where in United States
- VA Connecticut Healthcare SystemWest Haven, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Yale University
- Trial code
- NCT06513819
- Record updated
- 25 September 2026
- Original description
The focus of this pilot will be on falls and neurocognitive symptoms, and the impact of alcohol, cannabis use, and medications on these outcomes. The rationale is that alcohol use at any level may interact with neurocognitively active medications, alcohol, and cannabis use leading to falls and impaired cognition.Read full original descriptionShow less
The focus of this pilot will be on falls and neurocognitive symptoms, and the impact of alcohol, cannabis use, and medications on these outcomes. The rationale is that alcohol use at any level may interact with neurocognitively active medications, alcohol, and cannabis use leading to falls and impaired cognition.
Inclusion: HIV+; have visited a local VA site in within the past year; had an AUDIT-C indicating current alcohol use; taking 5 or more non-ART medications, including an NCAM (i.e., benzodiazepines, opioids, muscle relaxants, sleeping medication, and selective serotonin reuptake inhibitors).
Exclusion: Patients with an Alcohol Use Disorder (AUD) diagnosis in the past 12 months; Inpatient individuals; Patients who test positive on the Alcohol Symptom Checklist for moderate or severe AUD during the screening process.